References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
- Brewerton TD. Pharmacotherapy for patients with eating disorders. Psychiatr Times 2004; 21.
- Bruch H. Anorexia nervosa: therapy and theory. Am J Psychiatry 1982; 139: 1531–1538
- Stahl SM. Essential psychopharmacology, neuroscientific basis and practical applications2nd edn. Cambridge University Press, Cambridge 2000
- Wang TS, Chou YH, Shiah IS. Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 306–309
- NICE. Eating disorders: anorexia nervosa, bulimia nervosa and related eating disorders. London: National Institute for Clinical Excellence, 2004. [Accessed March 6 2006.] Available from URL: http://www.bps.org.uk/downloadfile.cfm?file_uuid=C1173310-7E96-C67F-D396-ADF1B891F5A3&ext=pdf.
- Lewinsohn PM, Striegel-Moore RH, Seeley JR. Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood. Am Acad Child Adolesc Psychiatry 2000; 39: 1284–1292
- Brewerton TD. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoendocrinology 1995; 20: 561–590
- Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res 1996; 62: 31–42
- Kaye WH, Gwirtsman HE, George TE, et al. CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 1988; 23: 102–105